Skip to main content
International Journal of Hypertension logoLink to International Journal of Hypertension
. 2019 Jan 23;2019:7320365. doi: 10.1155/2019/7320365

Blood Pressure Classification Using the Method of the Modular Neural Networks

Martha Pulido 1, Patricia Melin 1,, German Prado-Arechiga 2
PMCID: PMC6364108  PMID: 30809391

Abstract

In this paper, we present a new model based on modular neural networks (MNN) to classify a patient's blood pressure level (systolic and diastolic pressure and pulse). Tests are performed with the Levenberg-Marquardt (trainlm) and scaled conjugate gradient backpropagation (traincsg) training methods. The modular neural network architecture is formed by three modules. In the first module we consider the diastolic pressure data; in the second module we use details of the systolic pressure; in the third module, pulse data is used and the response integration is performed with the average method. The goal is to design the best MNN architecture for achieving an accurate classification. The results of the model show that MNN presents an excellent classification for blood pressure. The contribution of this work is related to helping the cardiologist in providing a good diagnosis and patient treatment and allows the analysis of the behavior of blood pressure in relation to the corresponding diagnosis, in order to prevent heart disease.

1. Introduction

The learning ability of neural networks and their pattern classification characteristics are the reasons why these models can be of great importance for medical applications. Nowadays there are many approaches in intelligent computing, such as evolutionary computing, fuzzy systems [17] and neural networks [818], which are used in the areas of medicine [1722].

Hypertension that threatens to be present in most of the people of the world is a dangerous disease and leads to fatal consequences such as death and is a risk factor for people who suffer from it: obesity, diabetes mellitus, etc.

Hypertension is a global problem as it affects more than a billion people and causes more than ten million (avoidable) deaths each year. The only way to know if a person suffers from this disease is to constantly check the blood pressure and effectively diagnose and prevent this disease [23, 24].

Currently, there are several computer techniques that have been applied in medicine, such as neural networks and fuzzy systems to diagnose hypertension; by using these methods we can provide information about the factors and risks the patient may have.

The main contribution of this work is the proposed Arterial Hypertension Classification and Diagnosis model based on modular neural networks for disease prevention. In this way, the cardiologist with the help of the model may prescribe the necessary treatment to the patient since hypertension is a disease that can evolve without showing any symptoms; this is the reason it is also known as “the silent killer”.

In this work, an MNN model is used to classify the patient's hypertension level, tests are also performed with the Levenberg-Marquardt (trainlm) and scaled conjugate gradient backpropagation (traincsg) training methods, and this neural network consists of three modules. In the first module we consider the diastolic pressure data; in the second module we use details of the systolic pressure; in the third module, pulse data is used. Therefore, we obtain the patient's blood pressure through ambulatory blood pressure monitoring (ABPM); so far we have 300 records.

1.1. Overview of Related Works

Artificial neural networks with the back propagation learning algorithm to obtain the hypertension diagnosis were presented by Sumathi B. et al. [25]. The method was designed with eight risk factors: smoking, stress, family history, high cholesterol, etc., where the result of neural network classification shows if the patient suffers from arterial hypertension.

Huang S. et al. [26] presented a study to investigate the factors of Hypertension (HTN) and was implemented as a prediction model for 35-year-old people in a rural area of China, with a modular neural network, considering risk factors, such as socioeconomic status and education level.

Vilkov V.G. et al. [13, 27] presented a comparative study with models of daily blood pressure monitoring was performed in 34 apparently healthy subjects and 72 patients with arterial hypertension (AH). They compared the efficiency of diagnosis of latent AH using models based on artificial neural networks of different architectures.

Barman M. et al. [28] presented an intelligent system based on a fuzzy rule system, to diagnose heart diseases and the number of heart attacks; such fuzzy system has seven inputs and uses the Cleveland database.

Patil P. et al. [29] designed a sensor which measures the pulse and temperature of the patient and is controlled by a fuzzy system which shows the patient's pulse via remote and sends a warning to relatives, doctors, or ambulances, in case it presents an emergency for patients.

Morsi I. et al. [30] presented a model to diagnose blood pressure. A group of 105 patients is used to design this model and another group with the same number of patients is used to test and thus check the efficiency of fuzzy systems in the field of medicine.

Hussein S. [31] analyzed the risk factors of hypertension and a model was designed for the prediction of rural residents over 35 years of age, considering several factors such as education level, sedentary work, and history of hypertension in the family.

Touyz M. R. et al. [32] presented an ANFIS system; methodology is designed to diagnose and compare an existing fuzzy expert system, regarding performance metrics accuracy and sensitivity.

1.2. Artificial Neural Networks

Neural networks are integrated by many interrelated components. A neural network can have a structure of multiple inputs and outputs; these systems operate similarly to the human brain. A neural network learns from input values, and this helps us learn about the human being [3335].

1.3. Hypertension

In Mexico, a large number of professional studies have been made with the idea of determining the prevalence of hypertension, defined as the frequency of the disease at a given time in a particular place. The most important studies use different methodological criteria, which make them difficult to compare. In these studies, different blood pressure levels are used to define this disease. They even propose an adequate standardization to measure it, which usually leads to overdiagnosis. The number of measurements made at the time of the survey, be it on the same day or on different days, impacts significantly the prevalence of the disease. Another study that was decided to be included on the findings reported is the study of heart diseases of San Antonio (ECSA), which includes Mexican-American population and has a branch in Mexico City: the study of diabetes in Mexico City (EDCM). In these studies, the prevalence and incidence of hypertension and other cardiovascular factors are also reported.

1.4. Arterial Hypertension

Hypertension may be essential (unknown etiology, but with hereditary background) or secondary (with demonstrable cause) and can also be isolated or as metabolic syndrome; this disease is incapacitating and deadly due to the damage caused to important organs: blood vessels, heart, kidney, and eyes. Normal levels of blood pressure are those below 139/89 mmHg; secondary hypertension can be suspected in young people younger than 35 years of age or when there is no hypertension history in the family or in the absence of a family. Treatment of hypertension helps reducing damage to organs or even reverses it if possible; this treatment may be a drug with antidepressant use or nonpharmacological treatment, which includes changes in hygienic-dietetic habits (reduction weight, stop smoking, and drinking alcoholic beverages).

1.4.1. Development of Systolic and Diastolic Hypertension

The risk of cardiovascular complications begins, apparently with blood pressure values of 115mmHg for systolic and 75 mmHg for diastolic. In the clinical area, several subtypes of hypertension determined by isolated elevations of systolic and diastolic, or the combination of both are used. These subgroups have their own natural history and present a different cardiovascular risk.

Isolated systolic hypertension (ISH) is common after 50 years of age, affecting nearly 50% of people between 50 and 59 years of age, reaching 90% in those over 80 years old. This subtype of hypertension reflects the increase in the stiffness of the aorta and great vessels without an increase in arteriolar resistance.

When there is an increase in arteriolar resistance combined with a lack of increased arterial stiffness, the isolated diastolic pressure subtype (IDP) occurs; this subtype predominates in people younger than 40, comprising almost 60% of the population [36].

1.4.2. Pulse Pressure

Hypertension includes calculating pulse pressure (PP), which is done by subtracting the diastolic pressure and systolic quantities [37, 38]. In the elderly, increased systolic blood pressure reflects an increase in the degree of stiffness of arteries; as a result, pulse pressure increases. This is related to an increased incidence of cardiovascular events. Blood pressure PP is closely related to the changes produced by age in people over 50, increasing diastolic coronary mortality rates, and after 60 they stop. To most people, pulse and systolic pressure values become the most important risk triggers.

Previously, the pulse was measured when the examiner or physician would sit comfortably on the right side to support the patient's elbow and, with his right thumb, explore the antecubital fosse, where the brachial artery is. The patient's arm reflex should be activated. When the thumb or finger of the examiner is correctly in place, he or she can raise or lower the patient's forearm by varying the pressure applied to the artery, feeling the maximum pulse. The right thumb of the examiner can feel the patient's carotid artery similarly, which he or she may feel by gently grasping the patient's fingertips with theirs. The digital pulse can be counted exactly by simultaneously palpating the radial artery while the examiner supports the patient's wrist. The femoral pulse of a child of tender age should be sought only while the leg is relaxed voluntarily.

The arteries pulsations provide information about heart rhythms and speed, arterial pulse differential (right and left limbs, or top and bottom), thrills (shudders), and waveform. [39, 40].

Bradycardia. The bradycardia term simply means slower rate. Bradycardia athletes: the heart of an athlete is much more powerful than a normal person, which allows their heart force a greater volume of blood with each beat, a large proportion of blood driven into the arterial tree with each beat probably produces sufficient circulatory reflexes to begin causing bradycardia.

Tachycardia. Tachycardia means rapid heart rate. The three causes of tachycardia are increased body temperature and heart stimulation by the sympathetic and toxic states of the heart. Increased heart rate of about 10 beats per minute for each degree Celsius increases body temperature, up to 41°C; at this temperature, the heart rate may actually decrease by increasing muscle wasting as a result of fever. Tachycardia causes hyperthermia and increases the frequency of the heart rhythm [4145].

1.5. Ambulatory Blood Pressure Monitoring

Nowadays modern laboratory methods often require outpatient-monitoring equipment to measure a variety of the indicators for blood pressure (BP), for 24 hours continuously. The biological rhythms are physiological functions and pathological alterations. The BP with an average heart rate of 72 beats per minute and 103.680 pulse waves is produced with corresponding changes in BP [46]. While at first the method was used in research studies, it is now increasingly used in clinical practice, as it provides additional data of measures from office and home. Moreover, only the ABMP can shed some light on symptomatic episodes occurring within 24 hours, either by raising or lowering the BP [47]. This means that it can be used not only for diagnosis of arterial hypertension (HA), but also to evaluate the frequency and severity of acute episodes of hyper- or hypotension. The ABMP is very useful to investigate the effects of new drugs for a period of 24 hours.

2. The Proposed Method

This section presents the proposed method for blood pressure classification, which consists of designing of modular neural networks (MNN) and the integration of responses of MNN with an average method. The main goals are to implement and find the best MNN architecture; the MNN consists of three modules; the first module is for the systolic pressure, the next module is the diastolic pressure, and in the last module we have pulse, this way we classify the arterial hypertension of a person.

Figure 1 illustrates the MNN structure, which considers the diastolic, systolic pressure, and the pulse for the MNN inputs, and in this case has 3 modules. The tests are performed by changing the number of layers that are between 1 and 3 and the number of neurons from 1 to 50, and in this way we obtained the responses of the MNN and integrate them with the average integration method and we obtained the classification of blood pressure.

Figure 1.

Figure 1

General scheme of the method.

In Figure 2, we present the data used for the classification of the arterial hypertension, where 300 patient samples are used for training all the modules in the modular neural network and we considered other 40 patients for tests with 45 records for each patient in the complete architecture.

Figure 2.

Figure 2

Real data of the patients.

Table 1 presents the parameters of the MNN that are manually changed to obtain the best architecture.

Table 1.

MNN data.

Number of Layers Number of Neurons Epochs Learning Rate Error Goal Training Methods
1 to 3 1 to 50 500 0.001 0.01 (i) Levenberg-Marquardt (trainlm)
(ii) Scaled Conjugate Gradient Back Propagation (traincsg).

Table 2 presents the classification of arterial hypertension according to the European guidelines.

Table 2.

Blood pressure levels (mmHg).

Category Systolic Diastolic
Optimal <120 And <80

Normal 120-129 And/or 80-84

High Normal 130-139 And/or 85-89

Grade 1 Hypertension 140-159 And/or 90-99

Grade 2 Hypertension 160-179 And/or 100-109

Grade 3 Hypertension ≥180 And/or ≥110

Isolated Systolic hypertension ≥140 And/or <90

3. Discussion and Results

The proposed method to classify the blood pressure of a patient was validated with tests performed on 16 patients and positive results were obtained for the MNN.

The results of the best MNN architecture are shown in Figure 3. For each of the modules of the MNN, the goal error was of 0.002 and 500 epochs were used; the number of neurons used was 14 in the first layer and 15 in the second layer.

Figure 3.

Figure 3

The best architecture for MNN with the training method (trainlm).

Table 3 presents the results of the MNN with the “trainlm” method for the classification arterial hypertension.

Table 3.

Classification for MNN with train method (trainlm).

No. Persons Number of Neurons Time Systolic Diastolic Pulse Classification
Person1 14,15 00:06:48 118 70 68 Optimal

Person 2 14,15 00:06:48 109 77 76 Optimal

Person 3 14,15 00:06:48 112 76 79 Optimal

Person 4 14,15 00:06:48 120 73 73 Optimal

Person 5 14,15 00:06:48 146 86 77 Grade 1 Hypertension

Person 6 14,15 00:06:48 107 63 92 Optimal

Person 7 14,15 00:06:48 128 83 97 Normal

Person 8 14,15 00:06:48 112 66 96 Optimal

Person 9 14,15 00:06:48 130 76 73 Normal

Person 10 14,15 00:06:48 123 79 57 Normal

Person 11 14,15 00:06:48 138 65 65 High Normal

Person 12 14,15 00:06:48 138 84 74 High Normal

Person 13 14,15 00:06:48 123 76 79 Normal

Person 14 14,15 00:06:48 114 63 78 Optimal

Person 15 14,15 00:06:48 124 79 72 Normal

Person 16 14,15 00:06:48 134 84 89 High Normal

Person 17 14,15 00:06:48 125 77 80 Normal

Person 18 14,15 00:06:48 106 65 79 Optimal

Person 19 14,15 00:06:48 110 68 79 Optimal

Person 20 14,15 00:06:48 123 76 80 Normal

Person 21 14,15 00:06:48 115 72 76 Optimal

Person 22 14,15 00:06:48 112 73 78 Optimal

Person 23 14,15 00:06:48 122 76 77 Normal

Person 24 14,15 00:06:48 117 68 90 Optimal

Person 25 14,15 00:06:48 121 74 92 Optimal

Person 26 14,15 00:06:48 130 82 89 Normal

Person 27 14,15 00:06:48 121 63 86 Optimal

Person 28 14,15 00:06:48 112 73 90 Optimal

Person 29 14,15 00:06:48 123 82 80 Normal

Person 30 14,15 00:06:48 95 61 73 Optimal

Person 31 14,15 00:06:48 108 65 72 Optimal

Person 32 14,15 00:06:48 110 70 73 Optimal

Person 33 14,15 00:06:48 116 67 71 Normal

Person 34 14,15 00:06:48 130 86 80 Normal

Person 35 14,15 00:06:48 117 73 80 Optimal

Person 36 14,15 00:06:48 117 54 81 Optimal

Person 37 14,15 00:06:48 113 74 74 Optimal

Person 38 14,15 00:06:48 132 86 79 Normal

Person 39 14,15 00:06:48 128 80 78 Normal

Person 40 14,15 00:06:48 131 85 70 Normal

Table 4 presents the average of the test of the MNN for each of the patients.

Table 4.

Average results of the MNN with (trainlm).

Person Time Systolic Diastolic Pulse
Person 1 00:15:34 115 73 67

Person 2 00:15:34 105 72 77

Person 3 00:15:34 114 70 80

Person 4 00:15:34 119 71 72

Person 5 00:15:34 145 84 75

Person 6 00:15:34 104 61 90

Person 7 00:15:34 125 87 96

Person 8 00:15:34 109 64 73

Person 9 00:15:34 129 73 56

Person 10 00:15:34 122 77 65

Person 11 00:15:34 136 63 70

Person 12 00:15:34 136 81 71

Person 13 00:15:34 120 74 78

Person 14 00:15:34 110 62 77

Person 15 00:15:34 119 68 70

Person 16 00:15:34 131 82 80

Person 17 00:15:34 125 77 80

Person 18 00:15:34 106 65 79

Person 19 00:15:34 110 68 79

Person 20 00:15:34 123 76 80

Person 21 00:15:34 115 72 76

Person 22 00:15:34 112 73 78

Person 23 00:15:34 122 76 77

Person 24 00:15:34 117 68 90

Person 25 00:15:34 121 74 92

Person 26 00:15:34 130 82 89

Person 27 00:15:34 121 63 86

Person 28 00:15:34 112 73 90

Person 29 00:15:34 123 82 80

Person 30 00:15:34 95 61 73

Person 31 00:15:34 108 65 72

Person 32 00:15:34 110 70 73

Person 33 00:15:34 116 67 71

Person 34 00:15:34 130 86 80

Person 35 00:15:34 117 73 80

Person 36 00:15:34 117 54 81

Person 37 00:15:34 113 74 74

Person 38 00:15:34 132 86 79

Person 39 00:15:34 128 80 78

Person 40 00:15:34 131 85 70

The results of the best MNN architecture are shown in Figure 4. For each of the modules of the MNN, the goal error was of 0.002 and 500 epochs were use;, the number of neurons used was 26 in the first layer and 29 in the second layer.

Figure 4.

Figure 4

The best architecture for MNN with the training method (traincsg).

Table 5 presents the results of the MNN with the “trainscg” method for the classification of arterial hypertension.

Table 5.

Classification for MNN with train method (traincsg).

No. Persons Number of Neurons Time Systolic Diastolic Pulse Classification
Person1 26,29 00:07:12 116 72 67 Optimal

Person 2 26,29 00:07:12 106 72 77 Optimal

Person 3 26,29 00:07:12 114 70 80 Optimal

Person 4 26,29 00:07:12 119 71 72 Optimal

Person 5 26,29 00:07:12 145 84 75 Grade1 Hypertension

Person 6 26,29 00:07:12 107 61 90 Normal

Person 7 26,29 00:07:12 130 87 97 High Normal

Person 8 26,29 00:07:12 120 64 97 Optimal

Person 9 26,29 00:07:12 131 74 73 High Normal

Person 10 26,29 00:07:12 122 78 57 Normal

Person 11 26,29 00:07:12 136 63 65 High Normal

Person 12 26,29 00:07:12 135 75 70 High Normal

Person 13 26,29 00:07:12 120 75 78 Normal

Person14 26,29 00:07:12 117 72 77 Optimal

Person 15 26,29 00:07:12 121 69 70 Normal

Person 16 26,29 00:07:12 132 90 78 High Normal

Person 17 26,29 00:07:12 126 76 80 Normal

Person 18 26,29 00:07:12 106 65 82 Optimal

Person 19 26,29 00:07:12 110 68 84 Optimal

Person 20 26,29 00:07:12 123 76 90 Normal

Person 21 26,29 00:07:12 112 71 78 Optimal

Person 22 26,29 00:07:12 111 70 70 Optimal

Person 23 26,29 00:07:12 122 73 71 Normal

Person 24 26,29 00:07:12 116 67 80 Optimal

Person 25 26,29 00:07:12 120 74 80 Optimal

Person 26 26,29 00:07:12 129 80 79 Normal

Person 27 26,29 00:07:12 120 61 74 Optimal

Person 28 26,29 00:07:12 112 73 81 Optimal

Person 29 26,29 00:07:12 121 82 67 Normal

Person 30 26,29 00:07:12 95 61 77 Optimal

Person 31 26,29 00:07:12 106 65 80 Optimal

Person 32 26,29 00:07:12 116 75 72 Optimal

Person 33 26,29 00:07:12 116 71 75 Normal

Person 34 26,29 00:07:12 130 86 90 Normal

Person 35 26,29 00:07:12 117 74 97 Optimal

Person 36 26,29 00:07:12 117 58 88 Optimal

Person 37 26,29 00:07:12 113 70 73 Optimal

Person 38 26,29 00:07:12 131 71 80 Normal

Person 39 26,29 00:07:12 128 81 82 Normal

Person 40 26,29 00:07:12 134 85 81 Normal

In Table 6 the average of the test of the MNN for each of the persons is presented.

Table 6.

Average of the MNN with (traincsg).

Person Time Systolic Diastolic Pulse
Person 1 00:17:19 115 73 67

Person 2 00:17:19 105 72 77

Person 3 00:17:19 114 70 80

Person 4 00:17:19 119 71 72

Person 5 00:17:19 145 84 75

Person 6 00:17:19 104 61 90

Person 7 00:17:19 125 87 96

Person 8 00:17:19 109 64 73

Person 9 00:17:19 129 73 56

Person 10 00:17:19 122 77 65

Person 11 00:17:19 136 63 70

Person 12 00:17:19 136 81 71

Person 13 00:17:19 120 74 78

Person 14 00:17:19 110 62 77

Person 15 00:17:19 119 68 70

Person 16 00:17:19 131 82 80

Person 17 00:17:19 126 76 80

Person 18 00:17:19 106 65 82

Person 19 00:17:19 110 68 84

Person 20 00:17:19 123 76 90

Person 21 00:17:19 112 71 78

Person 22 00:17:19 111 70 70

Person 23 00:17:19 122 73 71

Person 24 00:17:19 116 67 80

Person 25 00:17:19 120 74 80

Person 26 00:17:19 129 80 79

Person 27 00:17:19 120 61 74

Person 28 00:17:19 112 73 81

Person 29 00:17:19 121 82 67

Person 30 00:17:19 95 61 77

Person 31 00:17:19 106 65 80

Person 32 00:17:19 116 75 72

Person 33 00:17:19 116 71 75

Person 34 00:17:19 130 86 90

Person 35 00:17:19 117 74 97

Person 36 00:17:19 117 58 88

Person 37 00:17:19 113 70 73

Person 38 00:17:19 131 71 80

Person 39 00:17:19 128 81 82

Person 40 00:17:19 134 85 81

Figure 5 presents the modeling data of diastolic pressure for the MNN; the pink line represents the real data and the green line represents data modeled with the MNN. The results of this model for the diastolic pressure that were obtained were good with respect to the records used to use the tests, since the trend according to the cardiologist was good.

Figure 5.

Figure 5

Modeling of diastolic pressure with the MNN.

Figure 6 presents the modeling data of systolic pressure with the MNN proposed; the pink line represents the real data and the green line represents data modeled with the MNN. The results of this model for the systolic pressure that were obtained were good with respect to the records used to use the tests, since the trend according to the cardiologist was good.

Figure 6.

Figure 6

Modeling of systolic pressure with the MNN.

Figure 7 present the modeling data of pulse pressure with the MNN; the pink line represents the real data and the green line represents data modeled with the modular neural network. The obtained results of this model for the pulse pressure were good with respect to the records used in the tests, since the trend according to the cardiologist is good.

Figure 7.

Figure 7

MNN modeling of pulse pressure.

4. Statistical Comparative Study

In this section a hypothesis test is made based on the errors obtained with the architecture of the modular network using the Levenberg-Marquardt learning method (trainlm) to obtain the trend of the systolic pressure. In addition, the results are compared with linear regression models based on the obtained errors.

The model used to perform the statistical comparison was the well-known linear regression. This model describes the relationship between a dependent variable and (also known as the output or answer) as a function of one or more independent variables X (called predictors). The general equation corresponding to a linear regression model is as follows:

y=β0+β1X+1 (1)

where

  • β represents a parameter that establishes the linear relationship between variables.

  • ϵ represents the random error terms.

  • X represents the real data.

  • y is the variable for classification.

The formulas to estimate the beta parameter values are given by

β0=y~β1x~ (2)
β1=xyxynx~y~x2nx~2 (3)

In this case the values for βo and β1 are the following (for each of the modules):

Module 1

  • βo =0.101663348532528

  • β1= 1.028385618868264

Module 2

  • βo = 0.04938271

  • β1= 1.024901397932274

Module 3

  • βo =0.565544448530641

  • β1= 1.104635529315485

A set of 30 experiments are carried out to compare the results; for this, we use the parametric Z test of two samples, which is used with the following formula:

Z=x1x2μ1μ2σx1x2 (4)

where

  • x-1-x-2 is the observed difference.

  •   (μ1μ2) is the expected difference.

  • σx-1-x-2 is the standard error of the difference.

The null hypothesis establishes that the mean of the errors of the systolic neural network are greater than or equal to the average of the errors obtained by the regression, being the alternative hypothesis that the mean of the errors of the systolic neural network are lower than the average of the errors obtained by the regression; the parameters of the hypothesis test are shown in Table 7.

Table 7.

Parameters for hypothesis testing modules.

Parameters
Confidence Interval 95%

Alfa 0.05

Ho μ 1μ2

Ha μ 1 < μ2

Critical Value Z= -1.645

In Table 8 we show the descriptive statistics for this test.

Table 8.

Descriptive statistics for Module 1 (systolic).

Variable Observations Mean Std. Derivation
MNN(sys) 30 9.820 1.997

Regression 30 16.830 4.508

Table 9 shows the results obtained by applying formula (1) for Module 1.

Table 9.

Results of the Z-test for Module 1.

Difference -7.010
z (Observed Value) -7.788

z (Critical Value) -1.645

p-value <3.33066907387547x10−15

Alfa 0.05

Since the result of the p value is lower than the level of significance alpha = 0.05, we reject the null hypothesis and accept the alternative hypothesis, so we can conclude that there is sufficient evidence with a 5% level of significance to support the claim that the means of the errors of the modular neural network for the obtaining of the systolic pressure tendency are smaller than those obtained by the regression method.

In Table 10 the descriptive statistics for Module 2 (diastolic) test is shown.

Table 10.

Descriptive statistics Module 2 (diastolic).

Variable Observations Mean Std. Derivation
MNN(sis) 30 23.177 3.096

Regression 30 34.778 5.438

Table 11 shows the results obtained by applying formula (1) for this test.

Table 11.

Results of the Z-test for Module 2.

Difference -9.462
z (Observed Value) -8.2383

z (Critical Value) -1.645

p-value <1.11022302462516x10−16

Alfa 0.05

Since the result of the p value is lower than the level of significance alpha = 0.05, we reject the null hypothesis and accept the alternative hypothesis, so we can conclude that there is sufficient evidence with a 5% level of significance to support the claim that the means of the errors of the modular neural network for the obtaining of the diastolic pressure tendency are smaller than those obtained by the regression method.

We show in Table 12 the descriptive statistics for Module 3 (pulse) test.

Table 12.

Descriptive statistics Module 3 (pulse).

Variable Observations Mean Std. Derivation
MNN(sis) 30 14.774 1.821

Regression 30 28.367 4.733

Table 13 shows the results obtained by applying formula (1) for the third module (pulse tendency).

Table 13.

Results of the Z-test Module 3.

Difference -13.593
z (Observed Value) -14.682

z (Critical Value) -1.645

p-value <2.59524148975464x10−17

Alfa 0.05

Since the result of the p value is less than the level of significance alpha = 0.05, we reject the null hypothesis and accept the alternative hypothesis, so we can conclude that there is sufficient evidence with a 5% level of significance to support the claim that the means of the errors of the modular neural network for obtaining the pulse tendency are smaller than those obtained by the regression method.

When comparing the model of the modular neural network with the linear regression models by means of the z-statistic tests, we can realize that when using intelligent computing techniques, in this case the modular neural networks, we have a more efficient technique to classify the systolic and diastolic pressure and the pulse and this could help the cardiologist detect and prevent diseases in the blood.

5. Conclusion

In this paper we have obtained good results with the proposed model. The MNN classification model for arterial hypertension was implemented with two training methods for the modular neural network, namely, the Scale Conjugate Gradient Backpropagation (trainscg) and Levenberg-Marquardt (trainlm), and we achieved good results with the second method (trainlm). Good results were also obtained in the diastolic, systolic, and pulse models, since the trend was good with respect to the records used to perform the tests. In addition, we have made a comparison between the neural network model and the regression equations, showing that the MNN model statistically outperforms the regression model. In this paper we conclude that this classification method is effective and could help the cardiologist to detect and prevent a patient's blood pressure.

Acknowledgments

We would like to express our gratitude to the CONACYT for Research Grant no. 246774 and Tijuana Institute of Technology for the facilities and resources granted for the development of this research.

Data Availability

The data that was used in this research to support the findings of this study are available from the corresponding author upon request by email pmelin@tectijuana.mx.

Conflicts of Interest

The authors declare that there are no conflicts of interest, financial or nonfinancial, with respect to this research study.

Authors' Contributions

The three authors of the paper were responsible for (1) concept and design of the system, (2) acquisition of data, (3) analysis and interpretation of data, and (4) preparation of the manuscript. The authors have agreed to authorship the paper and the order of authorship for this manuscript of this research.

References

  • 1.Abdullah A. A., Zakaria Z., Mohammad N. F. Design and development of fuzzy expert system for diagnosis of hypertension. Proceedings of the 2nd International Conference on Intelligent Systems, Modelling and Simulation (ISMS '11); January 2011; Kuala Lumpur, Malaysia. IEEE; pp. 113–117. [DOI] [Google Scholar]
  • 2.Abdullah A. A., Zakaria Z., Mohammad N. F. Design and development of fuzzy expert system for diagnosis of hypertension. Proceedings of the 2nd International Conference on Intelligent Systems, Modelling and Simulation (ISMS '11); January 2011; Kuala Lumpur, Malaysia. IEEE; pp. 131–141. [DOI] [Google Scholar]
  • 3.Kaur R., Kaur A. Hypertension Diagnosis Using Fuzzy Expert System. International Journal of Engineering Research and Applications (IJERA) 2014:2248–9622. [Google Scholar]
  • 4.Poli R., Cagnoni S., Coppini G., Valli G. A Neural Network Expert System for Diagnosing and Treating Hypertension. The Computer Journal. 1991;24(3):64–71. doi: 10.1109/2.73514. [DOI] [Google Scholar]
  • 5.Fuller R., Giove S. A Neuro-Fuzzy Approach to FMOLP Problems. Proceedings of CIFT94; 1994; Trento, Italy. pp. 97–101. [Google Scholar]
  • 6.Nohria R., Mann P. S. Diagnosis of Hypertension using Adaptive Neuro-Fuzzy Inference System. IJCST. 2015;6:2229–4333. [Google Scholar]
  • 7.Zeinab A., Hamid T. Design of a Fuzzy Expert System and A Multi-layer Neural Network System for Diagnosis of Hypertension. Vol. 2. Mashhad, Iran: Department of Computer Engineering, Mashhad Branch, Islamic Azad University; 2015. [Google Scholar]
  • 8.Yafawi R., Knauft M. E., Stokem K., Palminteri J. M., WirthJ M. Pulmonary arterial hypertension. Encyclopedia of Cardiovascular Research and Medecine. 2018:181–194. [Google Scholar]
  • 9.Kallistratos M. S., Poulimenos L. E., Manolis A. J. Atrial fibrillation and arterial hypertension. Pharmacological Research. 2018;128:322–326. doi: 10.1016/j.phrs.2017.10.007. [DOI] [PubMed] [Google Scholar]
  • 10.Cuspidi C., Tadic M., Grassi G., Mancia G. Treatment of hypertension: The ESH/ESC guidelines recommendations. Pharmacological Research. 2018;128:315–321. doi: 10.1016/j.phrs.2017.10.003. [DOI] [PubMed] [Google Scholar]
  • 11.Corrado A., Correale M., Mansueto N., et al. Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension. Microvascular Research. 2017;114:46–51. doi: 10.1016/j.mvr.2017.06.005. [DOI] [PubMed] [Google Scholar]
  • 12.Srivastava P., Srivastava A., Burande A., Khandelwal A. A note on hypertension classification scheme and soft computing decision making system. ISRN Biomathematics. 2013;11:13–22. [Google Scholar]
  • 13.Huang S., Xu Y., Yue L., et al. Evaluating the risk of hypertension using an artificial neural network method in rural residents over the age of 35 years in a Chinese area. Hypertension Research. 2010;33(7):722–726. doi: 10.1038/hr.2010.73. [DOI] [PubMed] [Google Scholar]
  • 14.Srivastava P., Srivastava A., Burande A., Khandelwal A. A note on hypertension classification scheme and soft computing decision making system. ISRN Biomathematics. 2013;12:20–23. doi: 10.1155/2013/342970.342970 [DOI] [Google Scholar]
  • 15.Ture M., Kurt I., Turhan Kurum A., Ozdamar K. Comparing classification techniques for predicting essential hypertension. Expert Systems with Applications. 2005;29(3):583–588. doi: 10.1016/j.eswa.2005.04.014. [DOI] [Google Scholar]
  • 16.Melin P., Miramontes I., Prado-Arechiga G. A hybrid model based on modular neural networks and fuzzy systems for classification of blood pressure and hypertension risk diagnosis. Expert Systems with Applications. 2018;107:146–164. doi: 10.1016/j.eswa.2018.04.023. [DOI] [Google Scholar]
  • 17.Melin P., Prado-Arechiga G. New Hybrid Intelligent Systems for Diagnosis and Risk Evaluation of Arterial Hypertension. Springer; 2018. [Google Scholar]
  • 18.Guzman J. C., Melin P., Prado-Arechiga G. Design of an optimized fuzzy classifier for the diagnosis of blood pressure with a new computational method for expert rule optimization. Algorithms. 2017;10(3):p. 79. [Google Scholar]
  • 19.Das S., Ghosh P. K., Kar S. Hypertension diagnosis: A comparative study using fuzzy expert system and neuro fuzzy system. Proceedings of the 2013 IEEE International Conference on Fuzzy Systems, FUZZ-IEEE 2013; July 2013; Durgapur, India. pp. 113–121. [Google Scholar]
  • 20.Djam X. Y., Kimbi Y. H. Fuzzy expert system for the management of hypertension. Pacific Journal of Science and Technology. 2011;11:390–402. [Google Scholar]
  • 21.Klabunde R. E. Cardiovascular Physiologic Concepts. 2nd: Wolters Kluwer Health; 2011. [Google Scholar]
  • 22.Ludmila I. K., Steimann F. Fuzzy Medical Diagnosis, School of Mathematics. Banggor, UK: University of Wales; 2008. [Google Scholar]
  • 23.Zhang H., Lin F. C. Medical Diagnosis by the Virtual Physician. IEEE Xplore Computer Based Medical System. 1999:296–302. [Google Scholar]
  • 24.Clec'h Y., Vicaut C., Marbeuf-G E., et al. Can fuzzy logic make things more clear? Critical Care. 2009;3(1):116–120. doi: 10.1186/cc7692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Grübler M. R., Gaksch M., Kienreich K., et al. Effects of Vitamin D3 on asymmetric- and symmetric dimethylarginine in arterial hypertension. The Journal of Steroid Biochemistry and Molecular Biology. 2018;175:157–163. doi: 10.1016/j.jsbmb.2016.12.014. [DOI] [PubMed] [Google Scholar]
  • 26.Sumathi B., Santhakumaran A. Pre-diagnosis of hypertension using artificial neural network. Global Journal of Computer Science and Technology, Coimbator, Tamil Nadu. 2011;3(6):21–32. [Google Scholar]
  • 27.Vilkov V. G., Oganov R. G., Shal'nova S. A. Comparative accuracy of neural network models for diagnosing latent arterial hypertension on the basis of data on daily blood pressure monitoring. Human Physiology. 2006;32(6):657–661. doi: 10.1134/S0362119706060053. [DOI] [PubMed] [Google Scholar]
  • 28.Kaur A., Bhardwaj A. Genetic neuro fuzzy system for hypertension diagnosis. International Journal of Computer Science and Information Technologies. 2014;5(4):4986–4989. [Google Scholar]
  • 29.Barman M., Choudhury J. A fuzzy rule base system for the diagnosis of heart disease. International Journal of Computer Applications. 2012:46–53. [Google Scholar]
  • 30.Patil P., Mohsin S. Fuzzy Logic based Health Care System using Wireless Body Area Network. International Journal of Computer Applications. 2013;80(12):46–51. doi: 10.5120/13917-1881. [DOI] [Google Scholar]
  • 31.Morsi I., Abd El Gawad Y. Z. Fuzzy logic in heart rate and blood pressure measuring system. Proceedings of the 8th IEEE Sensors Applications Symposium, SAS 2013; February 2013; Galveston, Tex, USA. IEEE; pp. 113–117. [Google Scholar]
  • 32.Hosseini S., Jutten C., Charbonnier S. Artificial Neural Nets Problem Solving Methods. Vol. 2687. Heidelberg, Germany: Springer; 2003. Neural network modeling of ambulatory systolic blood pressure for hypertension diagnosis; pp. 599–606. (Lecture Notes in Computer Science). [DOI] [Google Scholar]
  • 33.Touyz R. M., Lang N. N., Herrmann J., Van Den Meiracker A. H., Danser A. H. J. Recent Advances in Hypertension and Cardiovascular Toxicities With Vascular Endothel ial Growth Factor Inhibition. Recent Advances in Hypertension. 2017:1–3. doi: 10.1161/HYPERTENSIONAHA.117.08856. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Feng L., Khan A. H., Jehan I., Allen J., Jafar T. H. Albuminuria and kidney function as prognostic marker of left ventricular mass among South Asians with hypertension. Journal of the American Society of Hypertension. 2017;11(12):811–822.e2. doi: 10.1016/j.jash.2017.10.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Nierenberg J. L., Li C., He J., et al. Blood Pressure Genetic Risk Score Predicts Blood Pressure Responses to Dietary Sodium and Potassium: The GenSalt Study (Genetic Epidemiology Network of Salt Sensitivity) Hypertension (Dallas, Tex. : 1979) 2017;70(6):1106–1112. doi: 10.1161/HYPERTENSIONAHA.117.10108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Jang J. S. R., Sun C. T., Mizutani E. Neuro-Fuzzy and Soft Computing. Prentice Hall; 1996. [Google Scholar]
  • 37.Torlasco C., Faini A., Makil E., et al. Cardiovascular risk and hypertension control in Italy. Data from the 2015 World Hypertension Day. International Journal of Cardiology. 2017;243:529–532. doi: 10.1016/j.ijcard.2017.03.151. [DOI] [PubMed] [Google Scholar]
  • 38.Beevers G., Lip G. Y. H., O'brien E. Blood pressure measurement: Part I—Sphygmomanometry: Factors common to all techniques. BMJ. 2001;322(7292):p. 981. doi: 10.1136/bmj.322.7292.981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Bernstein D. Evaluation of the cardiovascular system: history and physical. In: Kliegman R. M., Stanton B. F., St. Geme J. W., editors. Evaluation. 2015. pp. 385–450. (Nelson Textbook of Pediatrics). [Google Scholar]
  • 40.Harrison. Principles of Internal Medicine. 19a. Vol. 2. McGraw-Hill; 2006. Tachyarrhythmias; pp. 2226–2232. Section 14. [Google Scholar]
  • 41.American Heart Association. 2016, https://www.heart.org/
  • 42.Simel D. L., Goldman L., Schafer A. I. Goldman's Cecil Medicine. 2012. Approach to the Patient: History and Physical Examination. [Google Scholar]
  • 43.World Health Organization. International Society of Hypertension Group. 2003 [Google Scholar]
  • 44.Whitworth J. A. World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. Journal of Hypertension. 2003;21(11):1983–1992. doi: 10.1097/00004872-200311000-00002. [DOI] [PubMed] [Google Scholar]
  • 45.Parati G., Mancia G. Ambulatory Blood Pressure Monitoring. In: Mancia G., Chalmers J., Julius S., et al., editors. Manual of Hypertension. London, UK: Churchill-Livingstone; 2002. pp. 153–171. [Google Scholar]
  • 46.Sokolow M. Ambulatory blood pressure a personal historical account. American Journal of Hypertension. 1993;6(6):1615–1655. doi: 10.1093/ajh/6.6.161S. J Hypertension; 20: 1917-1923. [DOI] [PubMed] [Google Scholar]
  • 47.Parati G., Mancia G. Ambulatory blood pressure monitoring in clinical practice. Journal of Hypertension. 2002;20(10):1925–1927. doi: 10.1097/00004872-200210000-00004. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data that was used in this research to support the findings of this study are available from the corresponding author upon request by email pmelin@tectijuana.mx.


Articles from International Journal of Hypertension are provided here courtesy of Wiley

RESOURCES